Pulse Biosciences
PLSE
55 hedge funds and large institutions have $19.9M invested in Pulse Biosciences in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 5 closing their positions.
1,200% more call options, than puts
Call options by funds: $13K | Put options by funds: $1K
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
15% more funds holding
Funds holding: 48 → 55 (+7)
0.51% more ownership
Funds ownership: 13.74% → 14.25% (+0.51%)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
67% less capital invested
Capital invested by funds: $59.8M → $19.9M (-$39.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.73M |
| 2 |
D.E. Shaw & Co
New York
|
+$827K |
| 3 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$748K |
| 4 |
Renaissance Technologies
New York
|
+$637K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$513K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.45M |
| 2 |
TF
TIAA FSB
Jacksonville,
Florida
|
-$404K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$172K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$164K |
| 5 |
Barclays
London,
United Kingdom
|
-$120K |
PLSE Hedge Fund Activity: Q1 2022 in Review
55 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2022, worth a combined $19.9M — down 67% from $59.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PLSE positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 21 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.73M. The largest seller was Granahan Investment Management, exiting entirely with an estimated $6.45M sold.
- 55 institutional investors held Pulse Biosciences (PLSE) as of Q1 2022, up from 48 in Q4 2021.
- Funds reported $19.9M of Pulse Biosciences stock for Q1 2022, down 67% quarter-over-quarter.
- 12 funds opened new Pulse Biosciences positions in Q1 2022 and 5 closed out, a net change of +7 holders.
- The largest Pulse Biosciences buyer in Q1 2022 was Morgan Stanley, an estimated $1.73M added.
- The largest Pulse Biosciences seller in Q1 2022 was Granahan Investment Management, an estimated $6.45M sold.
Based on aggregated 13F filings for Q1 2022.